NGNE Neurogene Inc.
Neurogene Inc. (NGNE) Insider Activity
What the officers, directors and large holders did with their own shares. Only open-market purchases and sales count toward the totals — grants, option exercises and shares withheld for tax are compensation mechanics, not decisions, and they're listed separately below.
How much of that selling was preplanned? 81% planned / 19% discretionary
Largest single sale: $155.7K.
Where they traded
No open-market insider purchase on record.
Recent open-market activity
| Date | Insider | Role | Action | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|---|
| Cvijic Christine Mikail | President and CFO | Sell 10b5-1 | 4,200 | $36.13 | $151.8K | 84,040 −4.8% of holding | |
| Cvijic Christine Mikail | President and CFO | Sell 10b5-1 | 600 | $36.02 | $21.6K | 88,240 −0.7% of holding | |
| Cvijic Christine Mikail 2 fills | President and CFO | Sell 10b5-1 | 4,061 | $34.82 | $141.4K | 90,370 −4.3% of holding | |
| Cvijic Christine Mikail | President and CFO | Sell 10b5-1 | 739 | $34.06 | $25.2K | 92,901 −0.8% of holding | |
| Cvijic Christine Mikail 2 fills | President and CFO | Sell 10b5-1 | 9,600 | $31.25 | $300.0K | 98,440 −8.9% of holding | |
| McMinn Rachel | Chief Executive Officer | Sell | 3,352 | $22.07 | $74.0K | 1,344,307 −0.2% of holding | |
| Cvijic Christine Mikail | President and CFO | Sell | 2,558 | $21.62 | $55.3K | 103,240 −2.4% of holding | |
| Jordan Julie | Chief Medical Officer | Sell | 828 | $21.89 | $18.1K | 12,472 −6.2% of holding |
Form 4s are due within two business days of a transaction, so this is close to real time — unlike the quarterly 13F data on the Institutional tab. A single large sale often reflects a prearranged 10b5-1 plan rather than a fresh view, so read a pattern of sales rather than any one of them.